Successful treatment with avapritinib in patient with mucosal metastatic melanoma

Metastatic vulvar melanoma is a rare and aggressive disease and survival is usually poor. Vulvar melanomas harbor BRAF V600 mutations only infrequently; consequently, target therapy is a rare therapeutic option and immunotherapy usually has only a weak effect. On the other hand, KIT mutations are ra...

Descripción completa

Detalles Bibliográficos
Autores principales: Cocorocchio, Emilia, Pala, Laura, Conforti, Fabio, Guerini-Rocco, Elena, De Pas, Tommaso, Ferrucci, Pier Francesco
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2020
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7406922/
https://www.ncbi.nlm.nih.gov/pubmed/32821296
http://dx.doi.org/10.1177/1758835920946158

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7406922/
https://www.ncbi.nlm.nih.gov/pubmed/32821296
http://dx.doi.org/10.1177/1758835920946158

Ejemplares similares